Back to tenders & grants page
Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required) Pharmaceutical & Medical Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required)
Receive Tenders like this by email

Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required)

Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required) has been closed on 30 Sep 2022. It no longer accepts any bids. For further information, you can contact the National Institutes of Health

Bellow, you can find more information about this project: 

Location: United States

General information

Donor:

National Institutes of Health

Industry:

Pharmaceutical & Medical

Status:

Closed

Timeline

Published:

21 Apr 2022

Deadline:

30 Sep 2022

Value:

3000000

Contacts

Name:

Kasia Bourcier, Ph.D.

Phone:

202-657-7589

Description

Get free access to our Tenders & Grants Database

Our service is free of charge and will always be

Join Now

Donors

Find out more